Skip to main content
. 2011 Sep 28;16(10):8257–8272. doi: 10.3390/molecules16108257

Figure 4.

Figure 4

Predicted vs. experimental vasorelaxant activities (−LogEC50) of the QSAR model developed by EMR-MLR.